CIBC Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.9M Buy
493,079
+10,613
+2% +$619K 0.07% 193
2025
Q4
$26M Buy
482,466
+196,274
+69% +$9.44M 0.06% 206
2025
Q3
$12.9M Buy
286,192
+12
+0% +$560 0.04% 267
2025
Q2
$13.2M Sell
286,180
-84,651
-23% -$4.16M 0.04% 257
2025
Q1
$22.6M Sell
370,831
-10,817
-3% -$631K 0.08% 178
2024
Q4
$21.6M Buy
381,648
+12,702
+3% +$710K 0.07% 183
2024
Q3
$19.1M Buy
368,946
+30,984
+9% +$1.45M 0.06% 189
2024
Q2
$14M Sell
337,962
-66,073
-16% -$2.96M 0.05% 209
2024
Q1
$21.9M Buy
404,035
+53,773
+15% +$2.74M 0.08% 159
2023
Q4
$18M Sell
350,262
-20,737
-6% -$1.09M 0.07% 176
2023
Q3
$21.5M Sell
370,999
-10,401
-3% -$637K 0.09% 148
2023
Q2
$24.4M Sell
381,400
-5,638
-1% -$378K 0.09% 148
2023
Q1
$26.8M Buy
387,038
+2,901
+0.8% +$205K 0.11% 136
2022
Q4
$27.6M Sell
384,137
-104,542
-21% -$7.88M 0.12% 127
2022
Q3
$34.7M Buy
488,679
+57,883
+13% +$4.2M 0.15% 105
2022
Q2
$33.2M Buy
430,796
+15,959
+4% +$1.22M 0.13% 106
2022
Q1
$30.3M Buy
414,837
+38,156
+10% +$2.56M 0.11% 117
2021
Q4
$23.5M Buy
376,681
+33,186
+10% +$1.95M 0.09% 142
2021
Q3
$20.3M Buy
343,495
+5,143
+2% +$339K 0.08% 150
2021
Q2
$22.6M Buy
338,352
+253
+0.1% +$16.5K 0.09% 135
2021
Q1
$21.3M Sell
338,099
-60,743
-15% -$3.78M 0.09% 135
2020
Q4
$24.7M Buy
398,842
+21,772
+6% +$1.34M 0.12% 126
2020
Q3
$22.7M Buy
377,070
+17,883
+5% +$1.08M 0.12% 124
2020
Q2
$21.1M Buy
359,187
+141,281
+65% +$8.45M 0.12% 111
2020
Q1
$12.1M Sell
217,906
-2,741
-1% -$168K 0.09% 136
2019
Q4
$14.2M Buy
220,647
+66,526
+43% +$3.81M 0.08% 116
2019
Q3
$7.82M Buy
154,121
+7,112
+5% +$334K 0.05% 178
2019
Q2
$6.67M Buy
147,009
+139
+0.1% +$6.47K 0.04% 198
2019
Q1
$7.01M Sell
146,870
-1,581
-1% -$78.8K 0.04% 189
2018
Q4
$7.72M Sell
148,451
-2,171
-1% -$117K 0.06% 144
2018
Q3
$9.35M Sell
150,622
-1,237
-0.8% -$73.4K 0.06% 140
2018
Q2
$8.4M Buy
151,859
+5,506
+4% +$297K 0.05% 148
2018
Q1
$9.26M Sell
146,353
-7,841
-5% -$504K 0.06% 132
2017
Q4
$9.45M Buy
154,194
+2,342
+2% +$146K 0.06% 142
2017
Q3
$9.68M Buy
151,852
+2,054
+1% +$120K 0.06% 132
2017
Q2
$8.35M Buy
149,798
+634
+0.4% +$34.5K 0.06% 139
2017
Q1
$8.11M Buy
149,164
+1,554
+1% +$85.2K 0.06% 141
2016
Q4
$8.63M Sell
147,610
-2,231
-1% -$122K 0.06% 129
2016
Q3
$8.08M Sell
149,841
-13,492
-8% -$867K 0.06% 142
2016
Q2
$12M Buy
163,333
+3,354
+2% +$237K 0.09% 104
2016
Q1
$10.2M Buy
159,979
+2,874
+2% +$181K 0.08% 115
2015
Q4
$10.8M Sell
157,105
-7,293
-4% -$482K 0.09% 106
2015
Q3
$9.73M Buy
164,398
+1,922
+1% +$122K 0.08% 114
2015
Q2
$10.8M Buy
162,476
+9,568
+6% +$631K 0.08% 108
2015
Q1
$9.86M Buy
152,908
+5,744
+4% +$360K 0.07% 114
2014
Q4
$8.69M Sell
147,164
-68,938
-32% -$3.89M 0.06% 125
2014
Q3
$11.1M Sell
216,102
-111,394
-34% -$5.56M 0.07% 103
2014
Q2
$15.9M Buy
327,496
+108,402
+49% +$5.34M 0.09% 98
2014
Q1
$11.4M Sell
219,094
-8,795
-4% -$468K 0.07% 120
2013
Q4
$12.1M Sell
227,889
-15,185
-6% -$774K 0.07% 114
2013
Q3
$11.2M Sell
243,074
-38,504
-14% -$1.69M 0.07% 107
2013
Q2
$12.6M Buy
+281,578
New +$12.2M 0.09% 98

Other funds holding BMY

CIBC Asset Management's BMY Position: Q1 2026 in Review

CIBC Asset Management increased its Bristol-Myers Squibb (BMY) stake by 2.2% in Q1 2026, buying an estimated $619K and bringing the position to 493,079 shares worth $29.9M. The position accounts for 0.07% of the portfolio, ranked #193.

CIBC Asset Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $34.7M in Q3 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • CIBC Asset Management held 493,079 shares of Bristol-Myers Squibb worth $29.9M as of Q1 2026.
  • CIBC Asset Management bought 10,613 Bristol-Myers Squibb shares in Q1 2026, an estimated $619K.
  • Bristol-Myers Squibb made up 0.07% of CIBC Asset Management's portfolio in Q1 2026, its #193 holding.
  • CIBC Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • CIBC Asset Management's Bristol-Myers Squibb position peaked at $34.7M in Q3 2022.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on CIBC Asset Management's 13F filing for Q1 2026, filed 12 May 2026.